Christopher Matheny

1.4k total citations
23 papers, 695 citations indexed

About

Christopher Matheny is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Christopher Matheny has authored 23 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Christopher Matheny's work include Cancer Immunotherapy and Biomarkers (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Immune Response and Inflammation (4 papers). Christopher Matheny is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Immune Response and Inflammation (4 papers). Christopher Matheny collaborates with scholars based in United States, United Kingdom and Netherlands. Christopher Matheny's co-authors include Gary M. Pollack, Kim L. R. Brouwer, Matthew W. Lamb, Xiaodong Yang, Jonathan Larkin, Liangfu Chen, Harma Ellens, Jean Shearin, Yu Xue and Jatinder K. Lamba and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Christopher Matheny

23 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Matheny United States 12 356 139 122 113 109 23 695
Brandon Swift United States 13 405 1.1× 183 1.3× 212 1.7× 40 0.4× 195 1.8× 23 861
Marius Dohse Germany 9 497 1.4× 157 1.1× 40 0.3× 56 0.5× 230 2.1× 13 788
Taiji Sawamoto Japan 17 159 0.4× 59 0.4× 51 0.4× 99 0.9× 100 0.9× 30 644
Mukul Minocha United States 13 256 0.7× 72 0.5× 54 0.4× 21 0.2× 151 1.4× 32 612
Jason M. Gow United States 11 266 0.7× 140 1.0× 103 0.8× 16 0.1× 157 1.4× 12 615
Parnian Zia‐Amirhosseini United States 11 112 0.3× 37 0.3× 111 0.9× 83 0.7× 142 1.3× 18 747
Carla Washington United States 13 264 0.7× 139 1.0× 44 0.4× 17 0.2× 178 1.6× 31 896
Martin Leníček Czechia 20 265 0.7× 196 1.4× 48 0.4× 55 0.5× 490 4.5× 65 1.2k
Soo Ryang Kim Japan 15 166 0.5× 22 0.2× 40 0.3× 60 0.5× 95 0.9× 87 880
Kumie Kage Japan 6 606 1.7× 218 1.6× 71 0.6× 13 0.1× 310 2.8× 7 802

Countries citing papers authored by Christopher Matheny

Since Specialization
Citations

This map shows the geographic impact of Christopher Matheny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Matheny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Matheny more than expected).

Fields of papers citing papers by Christopher Matheny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Matheny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Matheny. The network helps show where Christopher Matheny may publish in the future.

Co-authorship network of co-authors of Christopher Matheny

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Matheny. A scholar is included among the top collaborators of Christopher Matheny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Matheny. Christopher Matheny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aggarwal, Charu, Daniel H. Sterman, Fabien Maldonado, et al.. (2023). CAN-2409 plus prodrug with standard of care immune checkpoint inhibitor for patients with stage III/IV NSCLC.. Journal of Clinical Oncology. 41(16_suppl). TPS9162–TPS9162. 2 indexed citations
2.
Aggarwal, Charu, Andrew R. Haas, Sarah Gordon, et al.. (2022). First report of safety/tolerability and preliminary antitumor activity of CAN-2409 in inadequate responders to immune checkpoint inhibitors for stage III/IV NSCLC.. Journal of Clinical Oncology. 40(16_suppl). 9037–9037. 2 indexed citations
3.
Gan, Hui, Michael Millward, Mathilde Jalving, et al.. (2021). A Phase I, First-in-Human Study of GSK2849330, an Anti-HER3 Monoclonal Antibody, in HER3-Expressing Solid Tumors. The Oncologist. 26(10). e1844–e1853. 27 indexed citations
4.
5.
Oordt, C. Willemien Menke‐van der Houven van, Adam McGeoch, Mats Bergström, et al.. (2019). Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors. Journal of Nuclear Medicine. 60(7). 902–909. 58 indexed citations
6.
7.
Bhattacharya, Sabyasachi, Christopher Matheny, Niranjan Yanamandra, et al.. (2018). Synergy of TLR4 agonist GSK1795091, an innate immune activator, with agonistic antibody against co-stimulatory immune checkpoint molecule OX40 in cancer immunotherapy.. Journal of Clinical Oncology. 36(15_suppl). 12055–12055. 8 indexed citations
8.
9.
McGeoch, Adam, Mats Bergström, O. S. Hoekstra, et al.. (2017). ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors. Pure Amsterdam UMC. 44. 5 indexed citations
10.
11.
Larkin, Jonathan, Jean Shearin, Rosalie Matico, et al.. (2015). Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification. Osteoarthritis and Cartilage. 23(8). 1254–1266. 103 indexed citations
12.
Germaschewski, Fiona, Christopher Matheny, Jonathan Larkin, et al.. (2014). Quantitation OF ARGS aggrecan fragments in synovial fluid, serum and urine from osteoarthritis patients. Osteoarthritis and Cartilage. 22(5). 690–697. 39 indexed citations
13.
Hopson, Christopher B., Alfred Hahn, Katherine Sully, et al.. (2014). 300 Preclinical pharmacologic characterization of GSK2849330, a monoclonal AccretaMab® antibody with optimized ADCC and CDC activity directed against HER3. European Journal of Cancer. 50. 98–99. 9 indexed citations
14.
Bloomer, Jackie C., Geo Derimanov, Étienne Dumont, Harma Ellens, & Christopher Matheny. (2013). Optimizing thein vitroand clinical assessment of drug interaction risk by understanding co-medications in patient populations. Expert Opinion on Drug Metabolism & Toxicology. 9(6). 737–751. 11 indexed citations
15.
Mouly, Stéphane, Christopher Matheny, Mark Paine, et al.. (2005). Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5. Clinical Pharmacology & Therapeutics. 78(6). 605–618. 73 indexed citations
16.
Matheny, Christopher, et al.. (2004). EFFECT OF PROTOTYPICAL INDUCING AGENTS ON P-GLYCOPROTEIN AND CYP3A EXPRESSION IN MOUSE TISSUES. Drug Metabolism and Disposition. 32(9). 1008–1014. 59 indexed citations
17.
Matheny, Christopher, Matthew W. Lamb, Kim L. R. Brouwer, & Gary M. Pollack. (2001). Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(7). 778–796. 167 indexed citations
18.
Wermeling, Daniel P., Christopher Matheny, William J. John, et al.. (2000). Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration. Annals of Allergy Asthma & Immunology. 84(5). 528–532. 23 indexed citations
19.
Matheny, Christopher, et al.. (1999). A Pilot Study of Estrogen's Effects on Bronchial Myocyte Adhesion Molecule Expression. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(12). 1426–1431. 4 indexed citations
20.
Matheny, Christopher, David R. Taft, Kim L. R. Brouwer, & Gary M. Pollack. (1996). Evidence for reversible sequestration of morphine in rat liver. Biochemical Pharmacology. 52(4). 535–541. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brandon Swift Breakdown of academic impact, for papers by Marius Dohse Breakdown of academic impact, for papers by Taiji Sawamoto Breakdown of academic impact, for papers by Mukul Minocha Breakdown of academic impact, for papers by Jason M. Gow Breakdown of academic impact, for papers by Parnian Zia‐Amirhosseini Breakdown of academic impact, for papers by Carla Washington Breakdown of academic impact, for papers by Martin Leníček Breakdown of academic impact, for papers by Soo Ryang Kim Breakdown of academic impact, for papers by Kumie Kage
Rankless by CCL
2026